IVF Donor Mix-Up Allegations Raise Serious Questions for Families

Reports of IVF donor mix-ups in northern Cyprus have raised concerns among British families. Here is what is known about the allegations, DNA testing and donor identity.

IVF donor concerns emerge after treatment abroad

Reports of possible IVF donor mix-ups at fertility clinics in northern Cyprus have left families facing deeply upsetting questions about their children's biological origins.

An investigation has raised concerns that as many as 30 children may have been conceived using sperm or egg donors different from those selected by their parents. Most of the families affected are understood to be British, while many of the fertility procedures reportedly took place between 2012 and 2024.

The allegations centre particularly on the Dogus IVF Centre in Nicosia. Some parents who became concerned about their children's genetic backgrounds have subsequently arranged DNA testing. According to reports, at least 11 tests have indicated ancestry linked to Turkey or neighbouring regions, despite parents having selected donors described as being from Western Europe.

These findings have prompted serious questions about donor selection, record keeping, clinical oversight and the information provided to patients undergoing fertility treatment overseas.

Why donor selection matters in IVF

In vitro fertilisation, commonly known as IVF, is a fertility treatment in which an egg and sperm are combined in a laboratory to create an embryo. The embryo can then be transferred into the uterus in the hope of achieving a pregnancy.

For people using donor sperm or donor eggs, choosing a donor can be an intensely personal decision. Prospective parents may consider information such as medical history, physical characteristics, family background, education and interests.

The identity of an anonymous donor can also have significance for a donor-conceived person later in life. Genetic information may help them understand their biological heritage and identify potential medical risks.

This is why allegations that a different donor may have been used can have consequences extending far beyond the fertility treatment itself.

Families discover possible discrepancies through DNA tests

One reported case involves a mother referred to as Rachel, who underwent treatment at the Dogus clinic in 2012.

She had selected an anonymous Danish sperm donor but later became concerned that the donor's sperm might not have been used. After further investigation, Rachel and her son, Jonah, who is now 13, reportedly underwent DNA testing.

The results indicated that Jonah was Rachel's biological child but that the sperm donor used was not the donor she had selected.

For the family, the discovery reportedly raised questions about Jonah's biological identity and whether he may ever be able to find or contact the donor chosen by his mother.

The case illustrates why accurate fertility records and transparent donor information are considered so important. A donor's identity can become part of a person's understanding of their family history, even when the original treatment took place many years earlier.

Questions surrounding fertility clinics in northern Cyprus

The reports have also drawn attention to the regulation of fertility treatment in northern Cyprus.

Treatment in the region can be less expensive than private IVF treatment in the United Kingdom, making overseas fertility care attractive to some international patients. However, differences in regulation and oversight can create additional considerations for people travelling abroad for medical treatment.

The investigation reported that Cryos International, a major sperm bank, had blacklisted the Dogus clinic in 2016. Cryos reportedly said it had no record of supplying sperm to the clinic, despite claims that the clinic had promoted a relationship with the sperm bank.

The sperm bank has also reportedly suspended cooperation with another clinic, Miracle IVF, while an investigation takes place.

These claims have not established that every patient treated at the clinics experienced a donor mix-up. They instead highlight allegations involving a number of individual cases that are now attracting scrutiny.

Investigations and responses

Authorities in northern Cyprus reportedly confirmed that an investigation had been launched after the allegations first emerged. At the time of reporting, however, an update on the investigation had not been provided.

Several individuals connected with the clinics have also been named in reports concerning the cases. One doctor denied wrongdoing and said she had been cleared of breaches of relevant laws. Other individuals reportedly did not respond to questions from investigators or journalists.

The clinics involved have been approached for comment regarding the allegations.

It is important to distinguish between allegations, individual DNA findings and established facts. DNA results can demonstrate biological relationships, but they do not on their own establish how a particular clinical error occurred or who was responsible.

What the controversy means for IVF patients

The situation may encourage people considering fertility treatment abroad to ask detailed questions before proceeding.

Patients can ask clinics about donor sourcing, how donor samples are labelled and tracked, what documentation they will receive, and how treatment records will be maintained. They may also want to establish which country's regulations apply to the clinic and what avenues exist for complaints if something goes wrong.

Anyone considering donor conception should also understand how donor information is stored and whether the child may be able to access identifying information in the future, depending on the jurisdiction and the rules applicable to the treatment.

In the UK, fertility regulation is overseen by the Human Fertilisation and Embryology Authority, commonly known as the HFEA. However, treatment carried out overseas is not automatically subject to the same regulatory framework.

IVF costs and access in the UK

IVF access varies across the UK, with NHS funding decisions influenced by local policies. Private treatment can also be expensive, particularly when multiple cycles are required.

According to NHS guidance, eligibility for NHS-funded IVF depends on factors including age, fertility history and local commissioning criteria.

The cost and availability of treatment are important considerations, but families may also want to weigh the regulatory framework, clinic reputation, medical records and aftercare available when comparing treatment options in different countries.

The importance of knowing your biological origins

For donor-conceived people, discovering unexpected information about their genetic background can be emotionally difficult.

Organisations supporting donor-conceived people have stressed the importance of transparency about biological origins. Accurate records can also be relevant to medical history, particularly where inherited conditions or genetic risks are concerned.

The current allegations therefore raise broader questions about how fertility clinics protect patient information and ensure that donor material is correctly identified throughout treatment.

For affected families, the priority is likely to be establishing what happened in each individual case and ensuring that people have access to accurate information about their biological background.

Conclusion

The reported IVF donor mix-up allegations in northern Cyprus have raised serious concerns among families who travelled abroad in the hope of building their families.

While investigations continue, the cases underline the importance of reliable donor records, transparent fertility practices and strong clinical oversight. For people considering IVF abroad, understanding how donor material is sourced, identified and documented can be just as important as comparing treatment prices or success rates.

Most importantly, the allegations should not be interpreted as evidence that every overseas IVF treatment is unsafe or that every family treated at the clinics involved experienced an error. Each case requires careful investigation and verification.

Source: The Sun report, Aug 18, 2026 and publicly available NHS information regarding IVF.

Disclaimer: This article is for general information and should not be treated as medical, legal or fertility advice. Allegations described above should not be regarded as proven facts unless confirmed by the relevant investigation or authority. Anyone concerned about fertility treatment, donor records or genetic testing should seek advice from an appropriately qualified medical or legal professional.